Amanote Research
Register
Sign In
640. AdCD40L Immunostimulatory Gene Therapy in Combination With Cyclophosphamide Prolongs 6-Months Survival in a Phase I/Ii Trial for Malignant Melanoma
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35653-2
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV